About Sanjivani Paranteral Limited
Data last updated: 14 July 2026
Sanjivani Paranteral Limited is a public limited company based in Mumbai, Maharashtra, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 05 October 1994, the company has been in operation for over 32 years.
Registered with ROC Mumbai under CIN L24300MH1994PLC081752. Listed on BSE: 531569.
Capital: an authorised share capital of ₹15 Cr and a paid-up capital of ₹12.28 Cr. It is led by directors including Srivardhan Ashwani Khemka and Ashwani Anamisharan Khemka.
Last AGM: 26 September 2025. Financial statements filed for year ended 31 March 2025. Office: 205 P – N Kothari Indl Estatel B S Marg Bhandup (W), Mumbai, Maharashtra, India – 400078.
As per BSE-filed consolidated financials for FY 2026, the company reported a revenue of ₹68.67 Cr, a decline of 2.04% compared to the previous year. The net worth stands at ₹50.84 Cr (up 27.51% YoY). Total assets are valued at ₹87.97 Cr (up 12.5% YoY).
The company has a workforce of approximately 31 employees as per the latest available data. Its group structure includes 1 subsidiary.
The company is associated with 1 brand - Sanjivani Parenteral. As per MCA filings, the company has open charges of ₹8 Cr and satisfied charges of ₹192.05 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sanjivani.co.in.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social MediaLocked
-
Registered Address205 P – N Kothari Indl Estatel B S Marg Bhandup (W), Mumbai, Maharashtra, India – 400078
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Sanjivani Paranteral Limited
Sanjivani Paranteral Limited operates one associated brand: Sanjivani Parenteral. These brands represent Sanjivani Paranteral Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Generic injectables, oral solids, and sterile powders are manufactured. | sanjivani.co.in |
Business Activity of Sanjivani Paranteral Limited
Sanjivani Paranteral Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Sanjivani Paranteral Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Sanjivani Paranteral Limited
Sanjivani Paranteral Limited is audited by M/s R B GOHIL & CO (ICAI peer reviewed, certificate valid till 2027-12-31) for the financial year 2026, as reported in its BSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| M/s R B GOHIL & CO (ICAI peer reviewed, certificate valid till 2027-12-31) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of Sanjivani Paranteral Limited
Sanjivani Paranteral Limited is currently managed by 5 directors, with 12 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Srivardhan Ashwani Khemka | Director | 24 Mar 2022 | 4 Years 3 Months | Current |
|
Ashwani Anamisharan Khemka
Also directs:
Spl Infusion Private Limited, Genesen Labs Limited
|
Managing Director | 05 Oct 1994 | 31 Years 9 Months | Current |
|
Monika Amit Singhania
Also directs:
Dolat Algotech Limited, Lipi Data Systems Limited
|
Director | 24 Mar 2022 | 4 Years 3 Months | Current |
| Basant Shrivastava | Additional Director | 11 Sep 2025 | 0 Years 10 Months | Current |
| Abhay Milan Shah | Director | 08 Apr 2024 | 2 Years 3 Months | Current |
Financials of Sanjivani Paranteral Limited FY 2026 filings available
Sanjivani Paranteral Limited reported revenue of ₹68.67 Cr (down 2.04% YoY) for FY 2026.
| Metrics | FY 2026 | FY 2025 |
|---|---|---|
| Revenue from Operations | ₹68.67 Cr | ₹70.1 Cr |
| Other Income | ₹1.09 Cr | ₹1.22 Cr |
| Total Income | ₹69.76 Cr | ₹71.31 Cr |
| Cost of Materials Consumed | ₹43.53 Cr | ₹33.56 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 |
| Changes in Inventories | ₹4.53 Lakh | ₹6.92 Cr |
| Employee Benefit Expense | ₹7.01 Cr | ₹6.49 Cr |
| Finance Costs | ₹79.13 Lakh | ₹59.27 Lakh |
| Depreciation & Amortisation | ₹1.22 Cr | ₹62.09 Lakh |
| Other Expenses | ₹7.77 Cr | ₹12.77 Cr |
| Total Expenses | ₹60.36 Cr | ₹60.96 Cr |
| Profit Before Exceptional Items & Tax | ₹9.39 Cr | ₹10.35 Cr |
| Exceptional Items | ₹0 | ₹0 |
| Profit Before Tax | ₹9.39 Cr | ₹10.35 Cr |
| Total Tax Expense | ₹2.7 Cr | ₹2.26 Cr |
| Net Profit | ₹6.69 Cr | ₹8.09 Cr |
| Other Comprehensive Income | ₹0 | ₹0 |
| Total Comprehensive Income | ₹6.69 Cr | ₹8.09 Cr |
| EBITDA (computed) | ₹11.4 Cr | ₹11.57 Cr |
| Basic EPS | ₹5.49 | ₹6.89 |
| Diluted EPS | ₹5.49 | ₹6.66 |
| Metrics | FY 2026 | FY 2025 |
|---|---|---|
| Total Assets | ₹87.97 Cr | ₹78.2 Cr |
| Non-current Assets | ₹51.57 Cr | ₹44.02 Cr |
| Current Assets | ₹36.4 Cr | ₹34.18 Cr |
| Property, Plant & Equipment | ₹46.92 Cr | ₹20.56 Cr |
| Inventories | ₹11.02 Cr | ₹10.51 Cr |
| Trade Receivables | ₹15.43 Cr | ₹16.68 Cr |
| Cash & Equivalents | ₹1.24 Cr | ₹1.49 Cr |
| Equity (Net Worth) | ₹50.84 Cr | ₹39.87 Cr |
| Equity Share Capital | ₹12.28 Cr | ₹11.88 Cr |
| Borrowings (Non-current) | ₹8.57 Cr | ₹5.29 Cr |
| Borrowings (Current) | ₹5.71 Cr | ₹2.85 Cr |
| Total Debt (computed) | ₹14.28 Cr | ₹8.14 Cr |
| Current Liabilities | ₹26.39 Cr | ₹31.79 Cr |
| Total Liabilities | ₹37.13 Cr | ₹38.33 Cr |
| Metrics | FY 2026 | FY 2025 |
|---|---|---|
| Operating Cash Flow | ₹2.83 Lakh | ₹12.4 Cr |
| Investing Cash Flow | -₹9.97 Cr | -₹20.11 Cr |
| Financing Cash Flow | ₹9.7 Cr | ₹8.66 Cr |
| Capital Expenditure | ₹8.73 Cr | ₹30.35 Cr |
| Free Cash Flow (computed) | -₹8.7 Cr | -₹17.95 Cr |
| Dividends Paid | ₹61.42 Lakh | ₹0 |
| Net Change in Cash | -₹24.22 Lakh | ₹94.45 Lakh |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 |
|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹13.21 Cr | ₹22.06 Cr | ₹18.5 Cr | ₹17.89 Cr | ₹18.18 Cr | ₹17.35 Cr | ₹18.13 Cr |
| Other Income | ₹59.58 Lakh | ₹29.51 Lakh | ₹16.39 Lakh | ₹3.59 Lakh | ₹42.83 Lakh | ₹31.18 Lakh | ₹38.92 Lakh |
| Total Income | ₹13.81 Cr | ₹22.36 Cr | ₹18.66 Cr | ₹17.93 Cr | ₹18.61 Cr | ₹17.66 Cr | ₹18.52 Cr |
| Cost of Materials Consumed | ₹7.45 Cr | ₹14.02 Cr | ₹10.66 Cr | ₹11.4 Cr | ₹9.61 Cr | ₹10.11 Cr | ₹6.24 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | -₹5.44 Lakh | ₹71.46 Lakh | -₹32.44 Lakh | -₹29.05 Lakh | -₹21.42 Lakh | -₹18.49 Lakh | ₹4.66 Cr |
| Employee Benefit Expense | ₹2.24 Cr | ₹1.76 Cr | ₹1.49 Cr | ₹1.52 Cr | ₹2.11 Cr | ₹1.65 Cr | ₹1.61 Cr |
| Finance Costs | ₹31.4 Lakh | ₹20.86 Lakh | ₹4.96 Lakh | ₹21.91 Lakh | ₹20.25 Lakh | ₹19.39 Lakh | ₹18.04 Lakh |
| Depreciation & Amortisation | ₹65.69 Lakh | ₹22.73 Lakh | ₹16.85 Lakh | ₹16.36 Lakh | ₹18.39 Lakh | ₹15.9 Lakh | ₹14.55 Lakh |
| Other Expenses | ₹2 Cr | ₹1.73 Cr | ₹1.42 Cr | ₹2.61 Cr | ₹4.07 Cr | ₹3.22 Cr | ₹2.76 Cr |
| Total Expenses | ₹12.61 Cr | ₹18.66 Cr | ₹13.47 Cr | ₹15.63 Cr | ₹15.96 Cr | ₹15.15 Cr | ₹15.6 Cr |
| Profit Before Exceptional Items & Tax | ₹1.2 Cr | ₹3.7 Cr | ₹5.19 Cr | ₹2.3 Cr | ₹2.65 Cr | ₹2.51 Cr | ₹2.92 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹1.2 Cr | ₹3.7 Cr | ₹5.19 Cr | ₹2.3 Cr | ₹2.65 Cr | ₹2.51 Cr | ₹2.92 Cr |
| Total Tax Expense | ₹65.37 Lakh | ₹92.19 Lakh | ₹55.31 Lakh | ₹57 Lakh | ₹46.74 Lakh | ₹61.07 Lakh | ₹62 Lakh |
| Net Profit | ₹54.85 Lakh | ₹2.78 Cr | ₹4.64 Cr | ₹1.73 Cr | ₹2.19 Cr | ₹1.9 Cr | ₹2.3 Cr |
| Other Comprehensive Income | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Comprehensive Income | ₹54.85 Lakh | ₹2.78 Cr | ₹4.64 Cr | ₹1.73 Cr | ₹2.19 Cr | ₹1.9 Cr | ₹2.3 Cr |
| EBITDA (computed) | ₹2.17 Cr | ₹4.13 Cr | ₹5.41 Cr | ₹2.68 Cr | ₹3.04 Cr | ₹2.86 Cr | ₹3.24 Cr |
| Basic EPS | ₹0.49 | ₹2.21 | ₹3.78 | ₹1.46 | ₹1.84 | ₹1.62 | ₹1.96 |
| Diluted EPS | ₹0.49 | ₹2.21 | ₹3.78 | ₹1.41 | ₹1.61 | ₹1.62 | ₹1.96 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹64.76 Cr | ₹70.1 Cr | ₹54.41 Cr | ₹35.49 Cr | ₹30.61 Cr | ₹25.1 Cr | ₹16.36 Cr | ₹25.09 Cr |
| Other Income | ₹1.24 Cr | ₹1.21 Cr | ₹51.72 Lakh | ₹55.35 Lakh | ₹24.33 Lakh | ₹25.77 Lakh | ₹25.19 Lakh | ₹95.9 Lakh |
| Total Income | ₹66 Cr | ₹71.31 Cr | ₹54.93 Cr | ₹36.05 Cr | ₹30.86 Cr | ₹25.36 Cr | ₹16.61 Cr | ₹26.05 Cr |
| Cost of Materials Consumed | ₹41.65 Cr | ₹33.56 Cr | ₹34.37 Cr | ₹19.84 Cr | ₹12.66 Cr | ₹14.14 Cr | ₹9.93 Cr | ₹14.6 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | ₹27.67 Lakh | ₹6.92 Cr | -₹5.89 Cr | -₹1.28 Cr | -₹35.34 Lakh | ₹66.93 Lakh | -₹85.96 Lakh | ₹46.97 Lakh |
| Employee Benefit Expense | ₹6.33 Cr | ₹6.49 Cr | ₹4.1 Cr | ₹3.27 Cr | ₹3.09 Cr | ₹2.49 Cr | ₹2.61 Cr | ₹2.73 Cr |
| Finance Costs | ₹53.93 Lakh | ₹59.27 Lakh | ₹25.35 Lakh | ₹35.87 Lakh | ₹21.32 Lakh | ₹12.59 Lakh | ₹65.61 Lakh | ₹32.84 Lakh |
| Depreciation & Amortisation | ₹86.43 Lakh | ₹62.09 Lakh | ₹93.32 Lakh | ₹88.77 Lakh | ₹87.74 Lakh | ₹85.98 Lakh | ₹1.07 Cr | ₹1.17 Cr |
| Other Expenses | ₹7.11 Cr | ₹12.76 Cr | ₹13.59 Cr | ₹8.02 Cr | ₹9.5 Cr | ₹5.66 Cr | ₹5.01 Cr | ₹9.04 Cr |
| Total Expenses | ₹56.77 Cr | ₹60.95 Cr | ₹47.36 Cr | ₹31.1 Cr | ₹25.98 Cr | ₹23.95 Cr | ₹18.42 Cr | ₹28.35 Cr |
| Profit Before Exceptional Items & Tax | ₹9.23 Cr | ₹10.36 Cr | ₹7.57 Cr | ₹4.94 Cr | ₹4.88 Cr | ₹1.41 Cr | -₹1.81 Cr | -₹2.3 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹9.23 Cr | ₹10.36 Cr | ₹7.57 Cr | ₹4.94 Cr | ₹4.88 Cr | ₹1.41 Cr | -₹1.81 Cr | -₹2.3 Cr |
| Total Tax Expense | ₹2.31 Cr | ₹2.26 Cr | ₹1.41 Cr | ₹43.28 Lakh | ₹3.22 Lakh | -₹71,000 | -₹10.03 Lakh | -₹22.96 Lakh |
| Net Profit | ₹6.92 Cr | ₹8.1 Cr | ₹6.17 Cr | ₹4.51 Cr | ₹4.85 Cr | ₹1.42 Cr | -₹1.71 Cr | -₹2.07 Cr |
| Other Comprehensive Income | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Comprehensive Income | ₹6.92 Cr | ₹8.1 Cr | ₹6.17 Cr | ₹4.51 Cr | ₹4.85 Cr | ₹1.42 Cr | -₹1.71 Cr | -₹2.07 Cr |
| EBITDA (computed) | ₹10.63 Cr | ₹11.57 Cr | ₹8.76 Cr | ₹6.19 Cr | ₹5.97 Cr | ₹2.4 Cr | -₹8.03 Lakh | -₹79.74 Lakh |
| Basic EPS | ₹5.67 | ₹6.89 | ₹5.28 | ₹4.51 | ₹4.85 | ₹1.67 | ₹-2.90 | ₹-3.50 |
| Diluted EPS | ₹5.67 | ₹6.67 | ₹5.28 | ₹4.51 | ₹4.85 | ₹1.67 | ₹-2.90 | ₹-3.50 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹78.43 Cr | ₹65 Cr | ₹43.41 Cr | ₹21.01 Cr | ₹18.3 Cr | ₹19.28 Cr | ₹15.66 Cr | ₹17.97 Cr |
| Non-current Assets | ₹30.15 Cr | ₹26.89 Cr | ₹14.77 Cr | ₹12.74 Cr | ₹10.57 Cr | ₹10.09 Cr | ₹11.87 Cr | ₹10.91 Cr |
| Current Assets | ₹48.28 Cr | ₹38.1 Cr | ₹28.64 Cr | ₹8.27 Cr | ₹7.73 Cr | ₹9.18 Cr | ₹3.79 Cr | ₹7.06 Cr |
| Property, Plant & Equipment | ₹22.05 Cr | ₹20.56 Cr | ₹9.94 Cr | ₹7.57 Cr | ₹7.42 Cr | ₹7.62 Cr | ₹8.04 Cr | ₹8.99 Cr |
| Inventories | ₹9.54 Cr | ₹10.42 Cr | ₹9.73 Cr | ₹5.35 Cr | ₹1.75 Cr | ₹91.41 Lakh | ₹1.66 Cr | ₹56.29 Lakh |
| Trade Receivables | ₹11.01 Cr | ₹16.68 Cr | ₹4.7 Cr | ₹1.99 Cr | ₹4.92 Cr | ₹6.63 Cr | ₹1.07 Cr | ₹5.21 Cr |
| Cash & Equivalents | ₹1.15 Cr | ₹63.34 Lakh | ₹54.08 Lakh | ₹30.25 Lakh | ₹33.93 Lakh | ₹17.42 Lakh | ₹26.57 Lakh | ₹23.37 Lakh |
| Equity (Net Worth) | ₹48.39 Cr | ₹38 Cr | ₹27.9 Cr | -₹3.07 Cr | -₹7.58 Cr | -₹44.89 Cr | -₹48.91 Cr | -₹47.2 Cr |
| Equity Share Capital | ₹12.28 Cr | ₹11.88 Cr | ₹11.68 Cr | ₹10 Cr | ₹10 Cr | ₹8.5 Cr | ₹5.9 Cr | ₹5.9 Cr |
| Borrowings (Non-current) | ₹6.67 Cr | ₹5.29 Cr | ₹96.91 Lakh | ₹75.95 Lakh | ₹2.75 Cr | ₹5.3 Cr | ₹7.95 Cr | ₹8.13 Cr |
| Borrowings (Current) | ₹2.48 Cr | ₹33.61 Lakh | ₹0 | ₹1.73 Cr | ₹0 | ₹36.6 Cr | ₹26.92 Cr | ₹26.92 Cr |
| Total Debt (computed) | ₹9.15 Cr | ₹5.62 Cr | ₹96.91 Lakh | ₹2.49 Cr | ₹2.75 Cr | ₹41.9 Cr | ₹34.87 Cr | ₹35.05 Cr |
| Current Liabilities | ₹21.58 Cr | ₹20.46 Cr | ₹13.78 Cr | ₹22.65 Cr | ₹21.89 Cr | ₹57.63 Cr | ₹55.4 Cr | ₹55.67 Cr |
| Total Liabilities | ₹30.04 Cr | ₹27 Cr | ₹15.51 Cr | ₹24.08 Cr | ₹25.88 Cr | ₹64.17 Cr | ₹64.57 Cr | ₹65.18 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | -₹1.55 Cr | -₹23.86 Lakh | -₹10.7 Cr | ₹4.73 Cr | ₹8.52 Cr |
| Investing Cash Flow | -₹4.47 Cr | -₹5.81 Cr | -₹12.21 Cr | -₹1.04 Cr | -₹67.33 Lakh |
| Financing Cash Flow | ₹6.54 Cr | ₹6.14 Cr | ₹23.16 Cr | -₹3.73 Cr | -₹7.68 Cr |
| Capital Expenditure | ₹2.62 Cr | ₹11.24 Cr | ₹3.3 Cr | ₹1.1 Cr | ₹68.35 Lakh |
| Free Cash Flow (computed) | -₹4.17 Cr | -₹11.48 Cr | -₹14.01 Cr | ₹3.63 Cr | ₹7.84 Cr |
| Dividends Paid | ₹61.42 Lakh | ₹0 | ₹0 | ₹0 | ₹0 |
| Net Change in Cash | ₹51.64 Lakh | ₹9.26 Lakh | ₹23.83 Lakh | -₹3.68 Lakh | ₹16.51 Lakh |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹10.51 Cr | ₹20.86 Cr | ₹15.5 Cr | ₹17.89 Cr | ₹18.18 Cr | ₹17.35 Cr | ₹18.13 Cr | ₹16.44 Cr |
| Other Income | ₹74.69 Lakh | ₹29.05 Lakh | ₹16.39 Lakh | ₹3.59 Lakh | ₹42.68 Lakh | ₹31.18 Lakh | ₹38.92 Lakh | ₹8.57 Lakh |
| Total Income | ₹11.26 Cr | ₹21.15 Cr | ₹15.66 Cr | ₹17.93 Cr | ₹18.61 Cr | ₹17.66 Cr | ₹18.52 Cr | ₹16.52 Cr |
| Cost of Materials Consumed | ₹6.17 Cr | ₹13.41 Cr | ₹10.66 Cr | ₹11.4 Cr | ₹9.61 Cr | ₹10.11 Cr | ₹6.24 Cr | ₹7.6 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | ₹11.71 Lakh | ₹77.45 Lakh | -₹32.44 Lakh | -₹29.05 Lakh | -₹21.42 Lakh | -₹18.49 Lakh | ₹4.66 Cr | ₹2.66 Cr |
| Employee Benefit Expense | ₹1.69 Cr | ₹1.62 Cr | ₹1.49 Cr | ₹1.52 Cr | ₹2.11 Cr | ₹1.65 Cr | ₹1.61 Cr | ₹1.13 Cr |
| Finance Costs | ₹6.2 Lakh | ₹20.86 Lakh | ₹4.96 Lakh | ₹21.91 Lakh | ₹20.25 Lakh | ₹19.39 Lakh | ₹18.04 Lakh | ₹1.59 Lakh |
| Depreciation & Amortisation | ₹34.54 Lakh | ₹18.68 Lakh | ₹16.85 Lakh | ₹16.36 Lakh | ₹18.39 Lakh | ₹15.9 Lakh | ₹14.55 Lakh | ₹13.25 Lakh |
| Other Expenses | ₹1.62 Cr | ₹1.46 Cr | ₹1.42 Cr | ₹2.61 Cr | ₹4.06 Cr | ₹3.22 Cr | ₹2.76 Cr | ₹2.71 Cr |
| Total Expenses | ₹10.01 Cr | ₹17.67 Cr | ₹13.47 Cr | ₹15.63 Cr | ₹15.95 Cr | ₹15.15 Cr | ₹15.6 Cr | ₹14.25 Cr |
| Profit Before Exceptional Items & Tax | ₹1.25 Cr | ₹3.49 Cr | ₹2.19 Cr | ₹2.3 Cr | ₹2.66 Cr | ₹2.51 Cr | ₹2.92 Cr | ₹2.27 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹1.25 Cr | ₹3.49 Cr | ₹2.19 Cr | ₹2.3 Cr | ₹2.66 Cr | ₹2.51 Cr | ₹2.92 Cr | ₹2.27 Cr |
| Total Tax Expense | ₹31.31 Lakh | ₹87.19 Lakh | ₹55.31 Lakh | ₹57 Lakh | ₹46.74 Lakh | ₹61.07 Lakh | ₹62 Lakh | ₹56 Lakh |
| Net Profit | ₹93.74 Lakh | ₹2.62 Cr | ₹1.64 Cr | ₹1.73 Cr | ₹2.19 Cr | ₹1.9 Cr | ₹2.3 Cr | ₹1.71 Cr |
| Other Comprehensive Income | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Comprehensive Income | ₹93.74 Lakh | ₹2.62 Cr | ₹1.64 Cr | ₹1.73 Cr | ₹2.19 Cr | ₹1.9 Cr | ₹2.3 Cr | ₹1.71 Cr |
| EBITDA (computed) | ₹1.66 Cr | ₹3.88 Cr | ₹2.41 Cr | ₹2.68 Cr | ₹3.05 Cr | ₹2.86 Cr | ₹3.24 Cr | ₹2.42 Cr |
| Basic EPS | ₹0.80 | ₹2.13 | ₹1.33 | ₹1.46 | ₹1.84 | ₹1.62 | ₹1.96 | ₹0.00 |
| Diluted EPS | ₹0.80 | ₹2.13 | ₹1.33 | ₹1.41 | ₹1.62 | ₹1.62 | ₹1.96 | ₹0.00 |
Shareholding Pattern of Sanjivani Paranteral Limited
As per the shareholding pattern filed with BSE for the quarter ended Mar 2026, promoters hold 31.26%, domestic institutional investors hold 6.04%, retail and other public shareholders hold 62.71% of Sanjivani Paranteral Limited. The company had 5,933 shareholders on record.
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Promoters | 31.26% | 31.20% | 31.20% | 28.87% | 28.87% | 27.67% |
| Public | 68.74% | 68.80% | 68.80% | 71.13% | 71.13% | 72.33% |
| Mar 2026 | Mar 2025 | Mar 2024 | |
|---|---|---|---|
| Promoters | 31.26% | 28.87% | 27.67% |
| Public | 68.74% | 71.13% | 72.33% |
| Promoter change (YoY, %pts) | +2.39 | +1.20 | - |
Group Structure of Sanjivani Paranteral Limited
Sanjivani Paranteral Limited has 1 subsidiary company. This group structure data is as of FY 2024. The corporate group structure reflects Sanjivani Paranteral Limited's business expansion strategy and organizational complexity.
| Company Name | CIN | Shares Held |
|---|---|---|
| Spl Infusion Private Limited | U21001MH2024PTC419970 | - |
Showing major subsidiaries. Total: 1.
Charges & Borrowings of Sanjivani Paranteral Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Nov 2025 | Others | ₹1 Cr | Open |
| 25 Mar 2025 | Others | ₹1.5 Cr | Open |
| 14 Aug 2024 | Others | ₹50 Lakh | Open |
| 31 Jul 2024 | Others | ₹5 Cr | Open |
| 26 Jun 2015 | Others | ₹4 Cr | Satisfied |
Total charge records: 29 View all charges
Employees and EPFO Compliance at Sanjivani Paranteral Limited
Sanjivani Paranteral Limited has a workforce of 31 employees as of Mar 25, 2025.
Employee and EPFO history for Sanjivani Paranteral Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Sanjivani Paranteral Limited
GST registrations and filing compliance for Sanjivani Paranteral Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Sanjivani Paranteral Limited
Credit ratings, litigation, and regulatory alerts for Sanjivani Paranteral Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Sanjivani Paranteral Limited
MSME payment history for Sanjivani Paranteral Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Sanjivani Paranteral Limited
Corporate group structure for Sanjivani Paranteral Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Sanjivani Paranteral Limited
MCA filings and documents for Sanjivani Paranteral Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Sanjivani Paranteral Limited
Frequently Asked Questions about Sanjivani Paranteral Limited
Sanjivani Paranteral Limited is an active public limited company in the pharma sector based in Mumbai, Maharashtra, India. It was incorporated on 05 October 1994 (32+ years old) and is registered under CIN L24300MH1994PLC081752. Listed on BSE: 531569. The company has 31 employees.
Sanjivani Paranteral Limited reported revenue of ₹68.67 Cr for FY 2026 (down 2.04% YoY) based on consolidated BSE filings.
The current directors of Sanjivani Paranteral Limited are:
- Srivardhan Ashwani Khemka - Director
- Ashwani Anamisharan Khemka - Managing Director
- Monika Amit Singhania - Director
- Basant Shrivastava - Additional Director
- Abhay Milan Shah - Director
The primary industry of Sanjivani Paranteral Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Yes. Sanjivani Paranteral Limited is listed on BSE with code 531569.
Sanjivani Paranteral Limited can be reached at the registered office: 205 P – N Kothari Indl Estatel B S Marg Bhandup W, Mumbai, Maharashtra, India – 400078, or through the website sanjivani.co.in.